{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:40:17Z","timestamp":1718127617622},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s13277-015-4153-0","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T16:26:44Z","timestamp":1444321604000},"page":"3441-3449","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The influence of neoadjuvant therapy for the prognosis in patients with rectal carcinoma: a retrospective study"],"prefix":"10.1007","volume":"37","author":[{"given":"Qing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Ang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"4153_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"4153_CR2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/jclinpath-2014-202551","volume":"67","author":"CF Li","year":"2014","unstructured":"Li CF, He HL, Wang JY, Huang HY, Wu TF, Hsing CH, et al. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy. J Clin Pathol. 2014;67:1056\u201361.","journal-title":"J Clin Pathol"},{"key":"4153_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3322\/caac.20038","volume":"59","author":"MM Center","year":"2009","unstructured":"Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59:366\u201378.","journal-title":"CA Cancer J Clin"},{"key":"4153_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ijc.25653","volume":"129","author":"C Bosetti","year":"2011","unstructured":"Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, et al. Recent trends in colorectal cancer mortality in Europe. Int J Cancer. 2011;129:180\u201391.","journal-title":"Int J Cancer"},{"key":"4153_CR5","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490\u2013502.","journal-title":"Lancet"},{"key":"4153_CR6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.6004\/jnccn.2009.0057","volume":"7","author":"PF Engstrom","year":"2009","unstructured":"Engstrom PF, Arnoletti JP, Benson 3rd AB, Chen YJ, Choti MA, Cooper HS, et al. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Cancer Netw. 2009;7:838\u201381.","journal-title":"J Natl Compr Cancer Netw"},{"key":"4153_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W Gijn van","year":"2011","unstructured":"van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575\u201382.","journal-title":"Lancet Oncol"},{"key":"4153_CR8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","volume":"1","author":"RJ Heald","year":"1986","unstructured":"Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479\u201382.","journal-title":"Lancet"},{"key":"4153_CR9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ijrobp.2009.06.019","volume":"77","author":"TH Kim","year":"2010","unstructured":"Kim TH, Chang HJ, Kim DY, Jung KH, Hong YS, Kim SY, et al. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys. 2010;77:1158\u201365.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4153_CR10","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","volume":"23","author":"C Rodel","year":"2005","unstructured":"Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688\u201396.","journal-title":"J Clin Oncol"},{"key":"4153_CR11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1470-2045(14)70377-8","volume":"15","author":"YS Hong","year":"2014","unstructured":"Hong YS, Nam BH, Kim KP, Kim JE, Park SJ, Park YS, et al. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Lancet Oncol. 2014;15:1245\u201353.","journal-title":"Lancet Oncol"},{"key":"4153_CR12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.soc.2005.08.006","volume":"15","author":"J Kehoe","year":"2006","unstructured":"Kehoe J, Khatri VP. Staging and prognosis of colon cancer. Surg Oncol Clin N Am. 2006;15:129\u201346.","journal-title":"Surg Oncol Clin N Am"},{"key":"4153_CR13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/gut.2006.116830","volume":"56","author":"EJ Morris","year":"2007","unstructured":"Morris EJ, Maughan NJ, Forman D, Quirke P. Who to treat with adjuvant therapy in Dukes B\/stage II colorectal cancer? The need for high quality pathology. Gut. 2007;56:1419\u201325.","journal-title":"Gut"},{"key":"4153_CR14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114\u201323.","journal-title":"N Engl J Med"},{"key":"4153_CR15","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","volume":"26","author":"M Braendengen","year":"2008","unstructured":"Braendengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, Pahlman L, et al. Randomized phase iii study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol. 2008;26:3687\u201394.","journal-title":"J Clin Oncol"},{"key":"4153_CR16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","volume":"13","author":"RD Hofheinz","year":"2012","unstructured":"Hofheinz RD, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT, et al. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol. 2012;13:579\u201388.","journal-title":"Lancet Oncol"},{"key":"4153_CR17","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","volume":"24","author":"JP Gerard","year":"2006","unstructured":"Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620\u20135.","journal-title":"J Clin Oncol"},{"key":"4153_CR18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","volume":"13","author":"C Rodel","year":"2012","unstructured":"Rodel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012;13:679\u201387.","journal-title":"Lancet Oncol"},{"key":"4153_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrurol.2010.206","volume":"8","author":"MM Lange","year":"2011","unstructured":"Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol. 2011;8:51\u20137.","journal-title":"Nat Rev Urol"},{"key":"4153_CR20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00384-011-1288-3","volume":"26","author":"A Doeksen","year":"2011","unstructured":"Doeksen A, Gooszen JA, van Duijvendijk P, Tanis PJ, Bakx R, Slors JF, et al. Sexual and urinary functioning after rectal surgery: a prospective comparative study with a median follow-up of 8.5\u00a0years. Int J Color Dis. 2011;26:1549\u201357.","journal-title":"Int J Color Dis"},{"key":"4153_CR21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/1440-1681.12420","volume":"42","author":"JL Shan","year":"2015","unstructured":"Shan JL, Li Q, He ZX, Ren T, Zhou SF, Wang D. A population-based study elicits a reverse correlation between age and overall survival in elderly patients with rectal carcinoma receiving adjuvant chemotherapy. Clin Exp Pharmacol Physiol. 2015;42:752\u201365.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4153_CR22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0360-3016(02)02945-0","volume":"54","author":"LL Gunderson","year":"2002","unstructured":"Gunderson LL, Sargent DJ, Tepper JE, O\u2019Connell MJ, Allmer C, Smalley SR, et al. Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Radiat Oncol Biol Phys. 2002;54:386\u201396.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4153_CR23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1245\/s10434-006-9171-0","volume":"14","author":"SH Baik","year":"2007","unstructured":"Baik SH, Kim NK, Lee YC, Kim H, Lee KY, Sohn SK, et al. Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer. Ann Surg Oncol. 2007;14:462\u20139.","journal-title":"Ann Surg Oncol"},{"key":"4153_CR24","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/codi.12239","volume":"15","author":"H Cheung","year":"2013","unstructured":"Cheung H, Poon JT, Law WL. The impact of possum score on the long-term outcome of patients with rectal cancer. Color Dis. 2013;15:1171\u20136.","journal-title":"Color Dis"},{"key":"4153_CR25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clcc.2014.05.004","volume":"13","author":"A Stefano De","year":"2014","unstructured":"De Stefano A, Moretto R, Bucci L, Pepe S, Romano FJ, Cella AC, et al. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? Clin Colorectal Cancer. 2014;13:185\u201391.","journal-title":"Clin Colorectal Cancer"},{"key":"4153_CR26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1470-2045(14)70016-6","volume":"15","author":"GL Beets","year":"2014","unstructured":"Beets GL, Glimelius BL. Adjuvant chemotherapy for rectal cancer still controversial. Lancet Oncol. 2014;15:130\u20131.","journal-title":"Lancet Oncol"},{"key":"4153_CR27","first-page":"Cd004078","volume":"3","author":"SH Petersen","year":"2012","unstructured":"Petersen SH, Harling H, Kirkeby LT, Wille-Jorgensen P, Mocellin S. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev. 2012;3:Cd004078.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4153-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4153-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4153-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4153-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:18:34Z","timestamp":1718126314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4153-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["4153"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4153-0","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}